Archive

EMA Annual Report: 114 new medicines in 2024

Written by | 27 Jun 2025

The European Medicines Agency (EMA) – the EU’s drug safety watchdog – approved 114 medicines last year, with 46 of these having a new active substance which had […]

EU regulators warn of ‘vulnerabilities’ in supply of radiopharmaceuticals

Written by | 21 May 2025

Europe faces limited supplies of medicines containing radioisotopes which are used to diagnose or treat cancer, according to EU-level and national drug regulators. Experts say European countries should […]

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Written by | 11 May 2025

Even for patients covered by Medicare, annual out-of-pocket costs for lifesaving cancer treatments taken in pill form have often exceeded $10,000—until recently. Thanks to changes in Medicare Part […]

Breast cancer death rates have stopped going down

Written by | 17 Mar 2025

A new paper in the Journal of Breast Imaging, published by Oxford University Press, indicates that breast cancer mortality rates have stopped declining in women older than age 74, and […]

Could the contraceptive pill reduce risk of ovarian cancer?

Written by | 6 Feb 2025

It’s a little pill with big responsibilities. But despite its primary role to prevent pregnancy, the contraceptive pill (or ‘the Pill’) could also help reduce the risk of ovarian […]

Urine-based test detects aggressive prostate cancer

Written by | 4 Feb 2025

Traditional approaches to prostate cancer screening involve blood tests, MRI, and biopsies. However, in addition to being uncomfortable, some of these procedures result in overdiagnosis of low-grade cancers. […]

Cancer drugs linked to severe chronic peripheral nerve pain for 4 in every 10 patients

Written by | 3 Feb 2025

Worldwide, cancer chemotherapy is linked to persistent severe peripheral nerve pain (neuropathy) for around 4 in every 10 patients treated with these drugs, suggests a pooled data analysis […]

Significant worldwide disparities in availability and timeliness of new cancer drugs

Written by | 14 Oct 2024

Despite considerable progress in the discovery and development of new cancer drugs, there are significant disparities in both the availability and timeliness of these medicines worldwide, with poorer […]

Ontario Institute for Cancer Research funding aims to speed the development of new drugs for some of the most common cancers

Written by | 4 Oct 2024

The Ontario Institute for Cancer Research (OICR) continues to support Ontario drug discovery research by funding high-quality investigations of new therapies for some of the most prevalent pediatric […]

New law regulating out-of-pocket drug spending saves cancer patients more than $7,000 a year, study finds

Written by | 21 Sep 2024

As prescription oral chemotherapies have become a common form of cancer treatment, some patients were paying more than $10,000 a year for medications. A new study finds that […]

Study finds regular aspirin use associated with greatest reduction in colorectal cancer among those most at risk

Written by | 4 Aug 2024

Regular aspirin may help lower risk of colorectal cancer in people with greater lifestyle-related risk factors for the disease, according to a study led by researchers at Mass […]

New test detects more cases of cervical cancer

Written by | 9 Jul 2024

Researchers at Karolinska Institutet in Sweden, in collaboration with the University of Innsbruck in Austria, have developed a simpler and more effective screening method for cervical cancer than […]

Newsletter Icon

Sign up to our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Sign Up

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our email journals and publications.